Comparison of the cyclophosphailiide (C), ara-c (A), topotecan (T), (CAT) regimen to ara-c plus topotecan or idarubicin (I) as initial therapy for patients with adverse abnormal karyotype acute myeloid leukemia (AML).

被引：0
|
作者：
Beran, H [1 ]
Giles, FJ [1 ]
Cortes, JE [1 ]
Thomas, DA [1 ]
Koller, C [1 ]
O'Brien, SM [1 ]
Keating, MJ [1 ]
Freireich, E [1 ]
Kantarjian, HM [1 ]
Estey, E [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4213
引用
收藏
页码：226B / 226B
页数：1
相关论文
共 50 条
  • [31] Treatment of de novo acute myelogenous leukemia (AML) with liposomal doxorubicin plus Ara-C
    Sanchez, BO
    Gonzalez, GA
    Cortes, J
    BLOOD, 2002, 100 (11) : 269B - 269B
  • [32] Cyclophosphamide (CTX), ara-C and topotecan (TOP) (CAT) in patients (pts) with refractory or relapsed acute leukemias and transformed chronic myelogenous leukemia (CML).
    Cortes, J
    Kantarjian, H
    Beran, M
    OBrien, S
    Koller, C
    Kornblau, S
    Andreeff, M
    Keating, M
    Freireich, EJ
    Estey, E
    BLOOD, 1997, 90 (10) : 2251 - 2251
  • [33] A phase I trial of Ara-C, Topotecan, and Gemtuzumab Ozogamicin (Mylotarg®) for advanced MDS and secondary or relapsed AML.
    Langston, AA
    Tanner, A
    Lonial, S
    Heffner, LT
    Smith, K
    Bucur, S
    Waller, EK
    Redei, I
    Winton, E
    BLOOD, 2003, 102 (11) : 333B - 333B
  • [34] A phase I trial of ara-C, topotecan, and gemtuzumab ozogamicin (Mylotarg®) for advanced MDS and secondary or relapsed AML.
    Langston, AA
    McMillan, S
    Lonial, S
    Smith, K
    Waller, EK
    Heffner, LT
    Bucur, S
    Redei, I
    Flowers, C
    Lechowicz, MJ
    Winton, E
    BLOOD, 2004, 104 (11) : 502A - 502A
  • [35] PHASE 1B RESULTS OF IDASANUTLIN plus CYTARABINE (ARA-C) IN ACUTE MYELOID LEUKEMIA (AML) PATIENTS (PTS)
    Martinelli, G.
    Papayannidis, C.
    Paolini, S.
    Yee, K.
    Vey, N.
    Drummond, M.
    Kelly, K.
    Dickinson, M.
    Lee, J. Hwan
    Seiter, K.
    Yoon, S. Soo
    Assouline, S.
    Kasner, M.
    Nichols, G.
    Middleton, S.
    Blotner, S.
    Zhi, J.
    Pierceall, W.
    Chen, L. C.
    HAEMATOLOGICA, 2017, 102 : 48 - 48
  • [36] PHASE 1B RESULTS OF IDASANUTLIN plus CYTARABINE (ARA-C) IN ACUTE MYELOID LEUKEMIA (AML) PATIENTS (PTS)
    Martinelli, G.
    Pappayannidis, C.
    Yee, K.
    Vey, N.
    Drummond, M.
    Kelly, K.
    Dickinson, M.
    Lee, J. H.
    Seiter, K.
    Yoon, S. S.
    Assouline, S.
    Kasner, M.
    Nichols, G.
    Middleton, S.
    Blotner, S.
    Zhi, J.
    Pierceall, W.
    Chen, L. C.
    HAEMATOLOGICA, 2016, 101 : 187 - 187
  • [37] A phase I/II study of idarubicin (Ida) with continuous infusion fludarabine (F-ara-A) and cytarabine (ara-C) for refractory or recurrent pediatric acute myeloid leukemia (AML)
    Leahey, A
    Kelly, K
    Rorke, LB
    Lange, B
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1997, 19 (04) : 304 - 308
  • [38] Amifostine (Ethoyl) in combination with topotecan and Ara-C for patients with poor risk myelodysplasia (MDS) and secondary acute myelogenous leukemia.
    Fung, HC
    Bhatia, R
    O'Donnell, M
    Stein, A
    Speilberger, R
    Cohen, S
    Popplewell, L
    Kashyap, A
    Hilger, J
    Ivers, B
    Slovak, M
    Forman, SJ
    BLOOD, 2000, 96 (11) : 260B - 261B
  • [39] Comparison of idarubicin plus ara-C-, fludarabine plus ara-C-, and topotecan plus ara-C-based regimens in treatment of newly diagnosed acute myeloid leukemia, refractory anemia with excess blasts in transformation, or refractory anemia with excess blasts
    Estey, EH
    Thall, PF
    Cortes, JE
    Giles, FJ
    O'Brien, S
    Pierce, SA
    Wang, XM
    Kantarjian, HM
    Beran, M
    BLOOD, 2001, 98 (13) : 3575 - 3583
  • [40] Distinct Proteomic Signaling Networks Stratify Responses to Ara-C Based Induction Therapy in Patients with Acute Myeloid Leukemia (AML).
    Minden, Mark
    Rosen, David
    Putta, Santosh
    Cohen, Aileen
    Francis-Lang, Helen
    Covey, Todd
    Woronicz, John
    Soper, David
    Long, Brian
    Cordeiro, James
    Panganiban-Lustan, Lootsie
    Banville, Steve
    Gayko, Urte
    Cesano, Alessandra
    Fantl, Wendy
    BLOOD, 2008, 112 (11) : 885 - 886
12345